首页> 外文期刊>Journal of Medical Radiation Sciences >Reducing cardiac doses: a novel multi-leaf collimator modification technique to reduce left anterior descending coronary artery dose in patients with left-sided breast cancer
【24h】

Reducing cardiac doses: a novel multi-leaf collimator modification technique to reduce left anterior descending coronary artery dose in patients with left-sided breast cancer

机译:降低心脏剂量:一种新型多叶准直器改良技术,可减少左侧乳腺癌患者冠状动脉左前降支

获取原文
           

摘要

Abstract Introduction When irradiating the left breast, a small portion of the heart and left anterior descending coronary artery (LAD) are often included in the treatment field. Deep inspiration breath-hold (DIBH) techniques reduce dose to coronary structures, but are resource intensive and may not be tolerated by all patients. The aim of this study was to evaluate a simple multi-leaf collimator (MLC) modification technique with respect to target coverage and organ-at-risk sparing. Methods Forty nine patients with left-sided breast cancer, planned with a simultaneous integrated boost technique were retrospectively replanned with additional shielding of the LAD. Dose to the target volumes (whole breast and boost) and organs at risk (heart, ipsilateral lung and LAD) were assessed on both plans. Results Significant dose reductions were observed for all organs at risk when LAD shielding was introduced, with a reduction in mean LAD dose of 7.0 Gy, mean LAD planning risk volume (PRV) dose of 5.9 Gy, maximum LAD dose of 12 Gy and mean heart dose of 0.73 Gy. Target volume coverage was clinically acceptable for 96% of patients, using the left anterior descending coronary artery shielded plan (LADSP). No difference was observed between the standard plan (SP) and LADSP in nine patients (18%). Conclusions For selected patients, the implementation of a simple MLC shielding technique can reduce the dose to cardiac structures, whilst maintaining breast and boost volume dosimetry. This technique is simple to implement and may be used as an alternative to DIBH for those patients who are unable to fulfill the selection criteria, or departments who are not resourced to perform DIBH.
机译:摘要简介照射左乳房时,治疗区域通常会包括一小部分心脏和左前降支冠状动脉(LAD)。深吸气屏息(DIBH)技术可减少冠状动脉结构的剂量,但需要大量资源,并且并非所有患者都可以忍受。这项研究的目的是评估一个简单的多叶准直器(MLC)修改技术有关目标覆盖率和器官风险保留。方法回顾性地对49例采用同步综合升压技术计划的左侧乳腺癌患者进行回顾性重新计划,同时附加LAD屏蔽。在两个计划中均评估了达到目标体积的剂量(整个乳房和增强的剂量)和处于危险中的器官(心脏,同侧肺和LAD)。结果引入LAD屏蔽后,观察到所有有风险的器官剂量均显着降低,平均LAD剂量降低7.0 Gy,平均LAD规划风险量(PRV)降低5.9 Gy,最大LAD剂量降低12 Gy,平均心脏剂量为0.73 Gy。使用左冠状动脉前降支屏蔽计划(LADSP),对于96%的患者,目标体积覆盖范围在临床上是可以接受的。 9名患者(18%)的标准计划(SP)和LADSP之间未观察到差异。结论对于选定的患者,实施简单的MLC屏蔽技术可以减少心脏结构的剂量,同时保持乳房和增加剂量剂量。对于无法满足选择标准的患者或没有资源进行DIBH的患者,该技术易于实施,并且可以用作DIBH的替代方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号